Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial

Cavender, MA; O'Donoghue, ML; Abbate, A; Aylward, P; Fox, KA; Glaser, RX; Park, JG; Lopez-Sendon, J; Steg, PG; Sabatine, MS; Morrow, DA

Morrow, DA (通讯作者),Brigham & Womens Hosp, TIMI Study Grp, Hale Bldg Transformat Med,60 Fanwood Rd, Boston, MA 02115 USA.

AMERICAN HEART JOURNAL, 2022; 243 (): 147

Abstract

Background p38 mitogen activated kinase (MAPK) mediates the response to pro-inflammatory cytokines following myocardial infarction (MI) and is inhibit......

Full Text Link